Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.16
+0.03000.96%
Post-market: 3.11-0.0500-1.58%16:54 EDT
Volume:338.68K
Turnover:1.06M
Market Cap:174.45M
PE:-2.80
High:3.20
Open:3.11
Low:3.07
Close:3.13
Loading ...

Promising Developments in Alzheimer’s Treatments Support Buy Rating for Voyager Therapeutics

TIPRANKS
·
10 Apr

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Apr

Promising Developments in Voyager Therapeutics’ Alzheimer’s Programs Highlight Potential of Dual Tau-Targeted Therapies

TIPRANKS
·
09 Apr

TD Cowen Keeps Their Buy Rating on Voyager Therapeutics (VYGR)

TIPRANKS
·
08 Apr

Top Executives Unload Thousands of Voyager Therapeutics Shares!

TIPRANKS
·
05 Apr

Voyager Therapeutics announces new data from two preclinical programs

TIPRANKS
·
31 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Teleflex (TFX) and Voyager Therapeutics (VYGR)

TIPRANKS
·
17 Mar

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Labcorp Holdings (LH) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
17 Mar

Voyager Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
14 Mar

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

Voyager Therapeutics: Strong Buy Rating Backed by Strategic Partnerships and Promising Pipeline

TIPRANKS
·
13 Mar

Voyager Therapeutics: Strong Financials and Promising Pipeline Drive Buy Rating

TIPRANKS
·
12 Mar

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
12 Mar

Voyager Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Mar

Voyager Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
12 Mar

Voyager Therapeutics reports Q4 EPS (59c), consensus (35c)

TIPRANKS
·
12 Mar

Voyager Therapeutics Q4 2024 GAAP EPS $(0.59) Misses $(0.38) Estimate, Sales $6.278M Miss $16.577M Estimate

Benzinga
·
12 Mar

Voyager Therapeutics Inc: Sees to Meet Planned Oper Expenses and Capex Needs Into Mid-2027

THOMSON REUTERS
·
12 Mar

Voyager Therapeutics Q4 Basic EPS USD -0.59

THOMSON REUTERS
·
12 Mar

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

GlobeNewswire
·
12 Mar